Our team is built on core areas of expertise, including clinical, regulatory, financial,
venture capital/ private equity, as well as solid relationships with scientists
and business development executives with major biotech and pharmaceutical companies
throughout the world.
Our management team is complemented by an experienced scientific advisory board and seasoned biotech and pharmaceutical executives, who serve in our board of directors.
Three core principles that guide BioCycive are:
- Keeping science as the primary driver for drug development and commercialization efforts.
- Focusing on our key stakeholders – patients, physicians and our investors
- Remaining efficient with our resources – time and capital. BioCycive identifies the highest priority projects first and executes them to build value for the company and our investors